Effects of anti-osteoporosis medications on fracture healing

Current Osteoporosis Reports

Volumn 9, Issue 3, 2011, Pages 149-155

  Jørgensen, Niklas R ^a   Schwarz, Peter ^a,b  

^a GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Anti osteoporotic; Bisphosphonates; Fracture healing; Osteoporosis; Parathyroid hormone

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; DENOSUMAB; PARATHYROID HORMONE; PARATHYROID HORMONE[1-34]; PLACEBO; STRONTIUM RANELATE; ZOLEDRONIC ACID;

AGING; ARTICLE; DOSE RESPONSE; DRUG EFFICACY; DRUG MEGADOSE; DRUG RESPONSE; FEMUR FRACTURE; FRACTURE HEALING; FRACTURE NONUNION; FRAGILITY FRACTURE; HIP FRACTURE; HORMONE DEFICIENCY; HUMAN; NONHUMAN; OSTEOPOROSIS; RISK REDUCTION; SINGLE DRUG DOSE; STRESS FRACTURE; TIBIA FRACTURE; TREATMENT OUTCOME; ULNA FRACTURE;

EID: 80054976274     PISSN: 15441873     EISSN: 15442241     Source Type: Journal    
DOI: 10.1007/s11914-011-0065-0     Document Type: Article

References (48)

1. Gaston MS, Simpson AH. Inhibition of fracture healing. J Bone Joint Surg Br. 2007;89:1553-60. (Pubitemid 351183403)
2. Hayda RA, Brighton CT, Esterhai JL, Jr. (1998) Pathophysiology of delayed healing. Clin. Orthop. Relat Res. S31-S40
3. Axelrad TW, Kakar S, Einhorn TA. New technologies for the enhancement of skeletal repair. Injury. 2007;38 Suppl 1:S49-62. (Pubitemid 46440930)
4. Quattrocchi E, Kourlas H. Teriparatide: a review. Clin Ther. 2004;26:841-54. (Pubitemid 38943033)
5. Wronski TJ, Yen CF, Qi H, Dann LM. Parathyroid hormone is more effective than estrogen or bisphosphonates for restoration of lost bone mass in ovariectomized rats. Endocrinology. 1993;132:823-31. (Pubitemid 23056145)
6. Sato M, Zeng GQ, Turner CH. Biosynthetic human parathyroid hormone (1-34) effects on bone quality in aged ovariectomized rats. Endocrinology. 1997;138:4330-7. (Pubitemid 27408478)
7. Jerome CP, Burr DB, Van Bibber T, Hock JM, Brommage R. Treatment with human parathyroid hormone (1-34) for 18 months increases cancellous bone volume and improves trabecular architecture in ovariectomized cynomolgus monkeys (Macaca fascicularis). Bone. 2001;28:150-9. (Pubitemid 32140971)
8. Sato M, Westmore M, Ma YL, Schmidt A, Zeng QQ, Glass EV, et al. Teriparatide [PTH(1-34)] strengthens the proximal femur of ovariectomized nonhuman primates despite increasing porosity. J Bone Miner Res. 2004;19:623-9. (Pubitemid 41071223)
9. Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster JY, et al. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med. 2001;344:1434-41. (Pubitemid 32402100)
10. Greenspan SL, Bone HG, Ettinger MP, Hanley DA, Lindsay R, Zanchetta JR, et al. Effect of recombinant human parathyroid hormone (1-84) on vertebral fracture and bone mineral density in postmenopausal women with osteoporosis: a randomized trial. Ann Intern Med. 2007;146:326-39. (Pubitemid 351650593)
11. Andreassen TT, Ejersted C, Oxlund H. Intermittent parathyroid hormone (1-34) treatment increases callus formation and mechanical strength of healing rat fractures. J Bone Miner Res. 1999;14:960-8. (Pubitemid 29262891)
12. Andreassen TT, Willick GE, Morley P, Whitfield JF. Treatment with parathyroid hormone hPTH(1-34), hPTH(1-31), and monocyclic hPTH(1-31) enhances fracture strength and callus amount after withdrawal fracture strength and callus mechanical quality continue to increase. Calcif Tissue Int. 2004;74:351-6. (Pubitemid 38480859)
13. Holzer G, Majeska RJ, Lundy MW, Hartke JR, Einhorn TA (1999) Parathyroid hormone enhances fracture healing. A preliminary report. Clin. Orthop. Relat Res. 258-263 (Pubitemid 29439363)
14. Komatsubara S, Mori S, Mashiba T, Nonaka K, Seki A, Akiyama T, et al. Human parathyroid hormone (1-34) accelerates the fracture healing process of woven to lamellar bone replacement and new cortical shell formation in rat femora. Bone. 2005;36:678-87. (Pubitemid 40602261)
15. Tagil M, McDonald MM, Morse A, Peacock L, Mikulec K, Amanat N, et al. Intermittent PTH(1-34) does not increase union rates in open rat femoral fractures and exhibits attenuated anabolic effects compared to closed fractures. Bone. 2010;46:852-9.
16. Manabe T, Mori S, Mashiba T, Kaji Y, Iwata K, Komatsubara S, et al. Human parathyroid hormone (1-34) accelerates natural fracture healing process in the femoral osteotomy model of cynomolgus monkeys. Bone. 2007;40:1475-82. (Pubitemid 46756411)
17. Jee WS, Yao W. Overview: animal models of osteopenia and osteoporosis. J Musculoskelet Neuronal Interact. 2001;1:193-207.
18. Tsiridis E, Morgan EF, Bancroft JM, Song M, Kain M, Gerstenfeld L, et al. Effects of OP-1 and PTH in a new experimental model for the study of metaphyseal bone healing. Res: J. Orthop; 2007.
19. Andreassen TT, Fledelius C, Ejersted C, Oxlund H. Increases in callus formation and mechanical strength of healing fractures in old rats treated with parathyroid hormone. Acta Orthop Scand. 2001;72:304-7. (Pubitemid 32613496)
20. Yingjie H, Ge Z, Yisheng W, Ling Q, Hung WY, Kwoksui L, et al. Changes of microstructure and mineralized tissue in the middle and late phase of osteoporotic fracture healing in rats. Bone. 2007;41:631-8. (Pubitemid 47385430)
21. McCann RM, Colleary G, Geddis C, Clarke SA, Jordan GR, Dickson GR, et al. Effect of osteoporosis on bone mineral density and fracture repair in a rat femoral fracture model. J Orthop Res. 2008;26:384-93.
22. Walsh WR, Sherman P, Howlett CR, Sonnabend DH, Ehrlich MG (1997) Fracture healing in a rat osteopenia model. Clin. Orthop. Relat Res. 218-27 (Pubitemid 27400821)
23. Namkung-Matthai H, Appleyard R, Jansen J, Hao LJ, Maastricht S, Swain M, et al. Osteoporosis influences the early period of fracture healing in a rat osteoporotic model. Bone. 2001;28:80-6. (Pubitemid 32112065)
24. Jahng JS, Kim HW. Effect of intermittent administration of parathyroid hormone on fracture healing in ovariectomized rats. Orthopedics. 2000;23:1089-94.
25. Komrakova M, Stuermer EK, Werner C, Wicke M, Kolios L, Sehmisch S, et al. Effect of human parathyroid hormone hPTH (1-34) applied at different regimes on fracture healing and muscle in ovariectomized and healthy rats. Bone. 2010;47:480-92.
26. Nozaka K, Miyakoshi N, Kasukawa Y, Maekawa S, Noguchi H, Shimada Y. Intermittent administration of human parathyroid hormone enhances bone formation and union at the site of cancellous bone osteotomy in normal and ovariectomized rats. Bone. 2008;42:90-7. (Pubitemid 350297177)
27. Gabet Y, Muller R, Levy J, Dimarchi R, Chorev M, Bab I, et al. Parathyroid hormone 1-34 enhances titanium implant anchorage in low-density trabecular bone: a correlative micro-computed tomographic and biomechanical analysis. Bone. 2006;39:276-82. (Pubitemid 43851377)
28. Shirota T, Tashiro M, Ohno K, Yamaguchi A. Effect of intermittent parathyroid hormone (1-34) treatment on the bone response after placement of titanium implants into the tibia of ovariectomized rats. J Oral Maxillofac Surg. 2003;61:471-80. (Pubitemid 36396977)
29. Ellegaard M, Jorgensen NR, Schwarz P (2010) Parathyroid hormone and bone healing. Calcif.Tissue Int. 87:1-13. This is a recent detailed review on the effects of PTH on fracture healing.
30. Aspenberg P, Genant HK, Johansson T, Nino AJ, See K, Krohn K, Garcia-Hernandez PA, Recknor CP, Einhorn TA, Dalsky GP, Mitlak BH, Fierlinger A, Lakshmanan MC (2009) Teriparatide for Acceleration of Fracture Repair in Humans: A Prospective, Randomized, Double-blind Study of 102 Postmenopausal Women with Distal Radial Fractures. J. Bone Miner. Res. One of very few studies demonstrating the clinical potential of teriparatide in the promotion of bone healing.
31. Aspenberg P, Johansson T (2010) Teriparatide improves early callus formation in distal radial fractures. Acta Orthop. 81:234-6. One of very few studies demonstrating the clinical potential of teriparatide in the promotion of bone healing.
32. Komatsu DE, Brune KA, Liu H, Schmidt AL, Han B, Zeng QQ, et al. Longitudinal in vivo analysis of the region-specific efficacy of parathyroid hormone in a rat cortical defect model. Endocrinology. 2009;150:1570-9.
33. Alkhiary YM, Gerstenfeld LC, Krall E, Westmore M, Sato M, Mitlak BH, et al. Enhancement of experimental fracture-healing by systemic administration of recombinant human parathyroid hormone (PTH 1-34). J Bone Joint Surg Am. 2005;87:731-41. (Pubitemid 40489347)
34. Shane E, Burr D, Ebeling PR, Abrahamsen B, Adler RA, Brown TD, et al. Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res. 2010;25:2267-94.
35. Matos MA, Tannuri U, Guarniero R. The effect of zoledronate during bone healing. J Orthop Traumatol. 2010;11:7-12.
36. Greiner SH, Wildemann B, Back DA, Alidoust M, Schwabe P, Haas NP, et al. Local application of zoledronic acid incorporated in a poly(D, L-lactide)-coated implant accelerates fracture healing in rats. Acta Orthop. 2008;79:717-25.
37. Saito M, Shiraishi A, Ito M, Sakai S, Hayakawa N, Mihara M, et al. Comparison of effects of alfacalcidol and alendronate on mechanical properties and bone collagen cross-links of callus in the fracture repair rat model. Bone. 2010;46:1170-9.
38. Sloan AV, Martin JR, Li S, Li J (2010) Parathyroid hormone and bisphosphonate have opposite effects on stress fracture repair. Bone 47:235-40. This is an important study demonstrating the opposite effects of PTH and bisphosphonates on fracture healing.
39. Colon-Emeric C, Nordsletten L, Olson S, Major N, Boonen S, Haentjens P, Mesenbrink P, Magaziner J, Adachi J, Lyles KW, Hyldstrup L, Bucci-Rechtweg C, Recknor C (2010) Association between timing of zoledronic acid infusion and hip fracture healing. Osteoporos. Int. One of the only studies to document the safety of zoledronic acid when used in patients recovering after hip fractures.
40. Rozental TD, Vazquez MA, Chacko AT, Ayogu N, Bouxsein ML (2009) Comparison of radiographic fracture healing in the distal radius for patients on and off bisphosphonate therapy. J.Hand Surg. Am. 34:595-602. Important and relevant study on the clinical effects of bisphosphonates on fracture healing in the distal radius.
41. Solomon HMC, Mogun H, Schneeweiss S. The relation between bisphosphonate use and non-union of fractures of the humerus in older adults. Osteoporos Int. 2009;20:895-901.
42. Alegre DN, Ribeiro C, Sousa C, Correia J, Silva L, de AL (2010) Possible benefits of strontium ranelate in complicated long bone fractures. Rheumatol. Int.
43. Cebesoy O, Tutar E, Kose KC, Baltaci Y, Bagci C. Effect of strontium ranelate on fracture healing in rat tibia. Joint Bone Spine. 2007;74:590-3. (Pubitemid 350236018)
44. Brüel A, Olsen J, Birkedal H, Risager M, Andreassen TT, Raffalt AC, et al. Strontium is incorporated into the fracture callus but does not influence the mechanical strength of healing rat fractures. Calcif Tissue Int. 2011;88:142-52.
45. Ozturan KE, Demir B, Yucel I, Cakici H, Yilmaz F, Haberal A (2011) Effect of strontium ranelate on fracture healing in the osteoporotic rats. J.Orthop.Res. 29:138-42. Interesting study on the effect of strontium on fracture healing in osteoporotic animals.
46. Habermann B, Kafchitsas K, Olender G, Augat P, Kurth A (2010) Strontium ranelate enhances callus strength more than PTH 1-34 in an osteoporotic rat model of fracture healing. Calcif. Tissue Int. 86:82-9. This study compares the effect of strontium ranelate and PTH(1-34) on fracture healing.
47. Li YF, Luo E, Feng G, Zhu SS, Li JH, Hu J. Systemic treatment with strontium ranelate promotes tibial fracture healing in ovariectomized rats. Osteoporos Int. 2010;21:1889-97.
48. Gerstenfeld LC, Sacks DJ, Pelis M, Mason ZD, Graves DT, Barrero M, Ominsky MS, Kostenuik PJ, Morgan EF, Einhorn TA (2009) Comparison of effects of the bisphosphonate alendronate versus the RANKL inhibitor denosumab on murine fracture healing. J. Bone Miner. Res. 24:196-208. One of the first studies to investigate the effect of denosumab on fracture healing.